{"transactions":[{"id":4618136,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the options vested on May 1, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options vests every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":133840,"derivative":{"exercise_price":1.35,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":4618135,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"gift","planned":true,"acquired":false,"shares":8800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":4618134,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":13200,"price":25.32,"value":334224.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":65050,"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":4618133,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:30:38.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":1.35,"value":24300.0,"ownership":{"direct":true},"balance_after":78250,"source":{"system":"sec-edgar","filing":"0001993684-26-000008","document":"form4-09152026_040933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993684/000199368426000008/form4-09152026_040933.xml","form_type":"4"}},{"id":689326,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T21:47:01.000Z","date":"2026-08-12","kind":"sale","planned":true,"acquired":false,"shares":11048,"price":27.25,"value":301058.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2026."}],"balance_after":92211,"source":{"system":"sec-edgar","filing":"0001808343-26-000010","document":"form4-08122026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000010/form4-08122026_090856.xml","form_type":"4"}},{"id":689325,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T21:47:01.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":62291,"price":26.23,"value":1633892.93,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by AMBHMC II LLC (\"ABHMC\") on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction report was $26.23, and the range of prices were between $26.00 and $26.48, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001808343-26-000010","document":"form4-08122026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000010/form4-08122026_090856.xml","form_type":"4"}},{"id":689324,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T21:47:01.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":10125,"price":26.07,"value":263958.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by AMBHMC II LLC (\"ABHMC\") on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $26.07, and the range of prices were between $26.005 and $26.14, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":62291,"source":{"system":"sec-edgar","filing":"0001808343-26-000010","document":"form4-08122026_090856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000010/form4-08122026_090856.xml","form_type":"4"}},{"id":691941,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-10T20:10:05.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":15248,"price":26.06,"value":397362.88,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by AMBHMC II LLC (\"ABHMC\") on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction report was $26.06, and the range of prices were between $26.00 and $26.25, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold\nat each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":72416,"source":{"system":"sec-edgar","filing":"0001808343-26-000009","document":"form4-08102026_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000009/form4-08102026_040801.xml","form_type":"4"}},{"id":691940,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-10T20:10:05.000Z","date":"2026-08-06","kind":"sale","planned":true,"acquired":false,"shares":20840,"price":26.06,"value":543090.4,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by AMBHMC II LLC (\"ABHMC\") on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $26.06, and the range of prices were between $26.00 and $26.3318, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":87664,"source":{"system":"sec-edgar","filing":"0001808343-26-000009","document":"form4-08102026_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000009/form4-08102026_040801.xml","form_type":"4"}},{"id":694082,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-06T22:30:38.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":false,"shares":40250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the options vested on July 29, 2026, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":120750,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":40250},"source":{"system":"sec-edgar","filing":"0001831215-26-000005","document":"form4-08062026_100833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/form4-08062026_100833.xml","form_type":"4"}},{"id":694081,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-06T22:30:38.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":false,"shares":50366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested on August 9, 2025, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":78542,"derivative":{"exercise_price":12.92,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":50366},"source":{"system":"sec-edgar","filing":"0001831215-26-000005","document":"form4-08062026_100833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/form4-08062026_100833.xml","form_type":"4"}},{"id":694080,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2026-08-06T22:30:38.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":90616,"price":25.09,"value":2273555.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $25.09, and the range of prices were between $25.00 and $25.295, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001831215-26-000005","document":"form4-08062026_100833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/form4-08062026_100833.xml","form_type":"4"}},{"id":694079,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2026-08-06T22:30:38.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":true,"shares":40250,"price":10.6,"value":426650.0,"ownership":{"direct":true},"balance_after":90616,"source":{"system":"sec-edgar","filing":"0001831215-26-000005","document":"form4-08062026_100833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/form4-08062026_100833.xml","form_type":"4"}},{"id":694078,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2026-08-06T22:30:38.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":true,"shares":50366,"price":12.92,"value":650728.72,"ownership":{"direct":true},"balance_after":50366,"source":{"system":"sec-edgar","filing":"0001831215-26-000005","document":"form4-08062026_100833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/form4-08062026_100833.xml","form_type":"4"}},{"id":702959,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:17.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001831215-26-000004","document":"form4-07272026_040712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000004/form4-07272026_040712.xml","form_type":"4"}},{"id":702958,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:17.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0001831215-26-000004","document":"form4-07272026_040712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000004/form4-07272026_040712.xml","form_type":"4"}},{"id":703056,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28591,"kind":"person","name":"Tsai Philip","position":1,"cik":"0002026600","reported_name":"Tsai Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:15.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":76500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":76500,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":76500},"source":{"system":"sec-edgar","filing":"0002026600-26-000002","document":"form4-07272026_040711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2026600/000202660026000002/form4-07272026_040711.xml","form_type":"4"}},{"id":703055,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28591,"kind":"person","name":"Tsai Philip","position":1,"cik":"0002026600","reported_name":"Tsai Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:15.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":38250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":81550,"source":{"system":"sec-edgar","filing":"0002026600-26-000002","document":"form4-07272026_040711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026600/000202660026000002/form4-07272026_040711.xml","form_type":"4"}},{"id":702957,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28534,"kind":"person","name":"Stoneman Sandra G.","position":1,"cik":"0001831144","reported_name":"Stoneman Sandra G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER & GC"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:14.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":76500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":76500,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":76500},"source":{"system":"sec-edgar","filing":"0001831144-26-000002","document":"form4-07272026_040709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183114426000002/form4-07272026_040709.xml","form_type":"4"}},{"id":702956,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28534,"kind":"person","name":"Stoneman Sandra G.","position":1,"cik":"0001831144","reported_name":"Stoneman Sandra G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER & GC"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:14.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":38250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":43805,"source":{"system":"sec-edgar","filing":"0001831144-26-000002","document":"form4-07272026_040709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183114426000002/form4-07272026_040709.xml","form_type":"4"}},{"id":702955,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:12.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":76500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":76500,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":76500},"source":{"system":"sec-edgar","filing":"0001993684-26-000006","document":"form4-07272026_040707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000006/form4-07272026_040707.xml","form_type":"4"}},{"id":702954,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:12.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":38250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":60250,"source":{"system":"sec-edgar","filing":"0001993684-26-000006","document":"form4-07272026_040707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000006/form4-07272026_040707.xml","form_type":"4"}},{"id":703045,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:10.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":94500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":94500,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":94500},"source":{"system":"sec-edgar","filing":"0001994071-26-000006","document":"form4-07272026_040705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000006/form4-07272026_040705.xml","form_type":"4"}},{"id":703044,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:10.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":101287,"source":{"system":"sec-edgar","filing":"0001994071-26-000006","document":"form4-07272026_040705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000006/form4-07272026_040705.xml","form_type":"4"}},{"id":702953,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:08.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":108000,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0001997584-26-000006","document":"form4-07272026_040703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000006/form4-07272026_040703.xml","form_type":"4"}},{"id":702952,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:08.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":69805,"source":{"system":"sec-edgar","filing":"0001997584-26-000006","document":"form4-07272026_040703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000006/form4-07272026_040703.xml","form_type":"4"}},{"id":703088,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:07.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":360000,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001167496-26-000005","document":"form4-07272026_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749626000005/form4-07272026_040701.xml","form_type":"4"}},{"id":703087,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:07.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":870704,"source":{"system":"sec-edgar","filing":"0001167496-26-000005","document":"form4-07272026_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749626000005/form4-07272026_040701.xml","form_type":"4"}},{"id":711799,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-09T21:38:38.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":false,"shares":1092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on August 9, 2025, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":128908,"derivative":{"exercise_price":12.92,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":1092},"source":{"system":"sec-edgar","filing":"0001831215-26-000002","document":"form4-07092026_090734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000002/form4-07092026_090734.xml","form_type":"4"}},{"id":711798,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-09T21:38:38.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":1092,"price":25,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001831215-26-000002","document":"form4-07092026_090734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000002/form4-07092026_090734.xml","form_type":"4"}},{"id":711797,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2026-07-09T21:38:38.000Z","date":"2026-07-07","kind":"exercise","planned":true,"acquired":true,"shares":1092,"price":12.92,"value":14108.64,"ownership":{"direct":true},"balance_after":1092,"source":{"system":"sec-edgar","filing":"0001831215-26-000002","document":"form4-07092026_090734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000183121526000002/form4-07092026_090734.xml","form_type":"4"}},{"id":713666,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T23:02:48.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":16906,"price":24.2,"value":409125.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by AMBHMC II LLC (\"ABHMC\") on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction report was $24.20, and the range of prices were between $24.00 and $24.58, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold\nat each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":108504,"source":{"system":"sec-edgar","filing":"0001808343-26-000007","document":"form4-07072026_110744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000007/form4-07072026_110744.xml","form_type":"4"}},{"id":713665,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T23:02:48.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":83094,"price":24.11,"value":2003396.34,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by AMBHMC II LLC (\"ABHMC\") on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $24.11, and the range of prices were between $24.00 and $24.29, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":125410,"source":{"system":"sec-edgar","filing":"0001808343-26-000007","document":"form4-07072026_110744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000007/form4-07072026_110744.xml","form_type":"4"}},{"id":713575,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on October 16, 2024, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":290000,"derivative":{"exercise_price":8.73,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713574,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":16072,"price":23.44,"value":376727.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction report was $23.44, and the range of prices were between $23.26 and $23.67, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":15805,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713573,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":16214,"price":22.76,"value":369030.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction report was $22.76, and the range of prices were between $22.26 and $23.25, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":31877,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713572,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":22714,"price":21.95,"value":498572.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $21.95, and the range of prices were between $21.26 and $22.25, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":48091,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713571,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":55000,"price":8.73,"value":480150.0,"ownership":{"direct":true},"balance_after":70805,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":718159,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-03T00:31:58.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":24335,"price":23.33,"value":567735.55,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to  Rule 10b5-1 trading plans adopted by ABHMC II LLC (\"ABHMC\") and Arsenal Bridge Venture II-B LLC (\"ABV II-B\"), each on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The weighted average sale price for the transaction report was $23.33, and the range of prices were between $23.03 and $23.67, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold\nat each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":208504,"source":{"system":"sec-edgar","filing":"0001808343-26-000005","document":"form4-07032026_120754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000005/form4-07032026_120754.xml","form_type":"4"}},{"id":718158,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-03T00:31:58.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":75665,"price":22.35,"value":1691112.75,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to  Rule 10b5-1 trading plans adopted by ABHMC II LLC (\"ABHMC\") and Arsenal Bridge Venture II-B LLC (\"ABV II-B\"), each on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction report was $22.35, and the range of prices were between $22.015 and $23.015, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold\nat each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"ABHMC owns the shares of Issuer common stock. The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common\nstock held by ABHMC.  The Reporting Person disclaims beneficial ownership of these shares, except to\nthe extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":232839,"source":{"system":"sec-edgar","filing":"0001808343-26-000005","document":"form4-07032026_120754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000005/form4-07032026_120754.xml","form_type":"4"}},{"id":718157,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-03T00:31:58.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":101050,"price":21.12,"value":2134176.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to  Rule 10b5-1 trading plans adopted by ABHMC II LLC (\"ABHMC\") and Arsenal Bridge Venture II-B LLC (\"ABV II-B\"), each on March 31, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold as follows: 100,000 shares were sold by ABHMC and 1,050 shares were sold ABV II-B."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction report was $21.12, and the range of prices were between $20.83 and $21.47, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares of Issuer common stock held by the Reporting Person prior to the transaction reported herein reflect pro rata distributions in kind for no additional consideration, effected by each of Arsenal Bridge Venture II LLC (\"ABV II\") and ABV II-B to their respective members, including ABHMC, the managing member of ABV II and ABV II-B. The receipt of such shares by the Reporting Person constituted a change in form of ownership and, therefore, was not required to be reported pursuant to Section 16, including Rule 16a-13. Following this transaction, ABHMC owns the remaining 308,504 shares of Issuer common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Person is a managing member and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common stock held by ABHMC and is a co-founder and holder of a power of attorney with the ability to exercise voting and investment power over the shares of Issuer common stock held by ABV II-B. The Reporting Person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Reporting Person is the beneficial owner of such shares."}],"balance_after":308504,"source":{"system":"sec-edgar","filing":"0001808343-26-000005","document":"form4-07032026_120754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000005/form4-07032026_120754.xml","form_type":"4"}},{"id":723933,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on October 16, 2024, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":345000,"derivative":{"exercise_price":8.73,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":723932,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":14420,"price":20.66,"value":297917.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction report was $20.66, and the range of prices were between $20.275 and $21.02, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":15805,"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":723931,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":40580,"price":19.56,"value":793744.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $19.56, and the range of prices were between $19.27 and $20.255, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":30225,"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":723930,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":55000,"price":8.73,"value":480150.0,"ownership":{"direct":true},"balance_after":70805,"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":734459,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-17T21:26:19.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001994071-26-000004","document":"form4-06172026_090615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000004/form4-06172026_090615.xml","form_type":"4"}},{"id":734458,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T21:26:19.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":18.23,"value":1093800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction report was $18.23, and the range of prices were between $17.95 and $18.66, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":54037,"source":{"system":"sec-edgar","filing":"0001994071-26-000004","document":"form4-06172026_090615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000004/form4-06172026_090615.xml","form_type":"4"}},{"id":734457,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-17T21:26:19.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":1.05,"value":63000.0,"ownership":{"direct":true},"balance_after":114037,"source":{"system":"sec-edgar","filing":"0001994071-26-000004","document":"form4-06172026_090615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000004/form4-06172026_090615.xml","form_type":"4"}},{"id":739720,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":38710,"kind":"person","name":"SWAIN SANDRA M","position":1,"cik":"0001908755","reported_name":"SWAIN SANDRA M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)`","published_at":"2026-06-12T21:58:33.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001908755-26-000001","document":"form4-06122026_090629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000190875526000001/form4-06122026_090629.xml","form_type":"4"}},{"id":739719,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:56:21.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001405684-26-000003","document":"form4-06122026_090615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000140568426000003/form4-06122026_090615.xml","form_type":"4"}},{"id":739717,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:54:12.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001221590-26-000018","document":"form4-06122026_090608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000018/form4-06122026_090608.xml","form_type":"4"}},{"id":739718,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":37074,"kind":"person","name":"Boylan James P","position":1,"cik":"0001953094","reported_name":"Boylan James P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:51:52.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Mr. Boylan's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001953094-26-000002","document":"form4-06122026_090648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000195309426000002/form4-06122026_090648.xml","form_type":"4"}},{"id":740049,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:48:32.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Barchas has agreed to receive and hold for the benefit of Arsenal Bridge Ventures any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Barchas disclaims beneficial ownership of, and all right, title and interest in, the reported securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to Mr. Barchas' continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001808343-26-000002","document":"form4-06122026_090628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834326000002/form4-06122026_090628.xml","form_type":"4"}},{"id":739714,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-12T21:45:41.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments, commencing from June 10, 2026 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":9897,"derivative":{"exercise_price":18.16,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001272181-26-000006","document":"form4-06122026_090636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000127218126000006/form4-06122026_090636.xml","form_type":"4"}},{"id":744561,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":19.27,"value":19270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026.  The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":43415,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744560,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":19.46,"value":68110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":42415,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744559,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":19.48,"value":116880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":38915,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744558,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":19.41,"value":194100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026.  The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":32915,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":744557,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:40:12.000Z","date":"2026-06-05","kind":"sale","planned":false,"acquired":false,"shares":500,"price":19.44,"value":9720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026.  The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026."}],"balance_after":42915,"source":{"system":"sec-edgar","filing":"0001221590-26-000015","document":"form4-06092026_090607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000015/form4-06092026_090607.xml","form_type":"4"}},{"id":771928,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T11:56:51.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":20.7,"value":103500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $20.70, and the range of prices were between $20.645 and $20.72, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":43415,"source":{"system":"sec-edgar","filing":"0001221590-26-000007","document":"form4-05192026_110547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000007/form4-05192026_110547.xml","form_type":"4"}},{"id":816262,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:48:14.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":9438,"price":21.64,"value":204238.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0001993684-26-000004","document":"form4-04032026_110409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000004/form4-04032026_110409.xml","form_type":"4"}},{"id":816986,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":false,"shares":39713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":39713},"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816985,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":false,"shares":31848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested."}],"balance_after":60000,"derivative":{"exercise_price":1.05,"expiration_date":"2033-03-22","underlying":"Common Stock","underlying_shares":31848},"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816984,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":1344,"price":22.48,"value":30213.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average purchase price for the transaction report was $22.48, and the range of prices were between $22.45 and $22.56, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":54037,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816983,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":63656,"price":21.91,"value":1394702.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average purchase price for the transaction report was $21.91, and the range of prices were between $21.44 and $22.44, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":55381,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816982,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":39713,"price":1.35,"value":53612.55,"ownership":{"direct":true},"balance_after":119037,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":816981,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-03T23:46:52.000Z","date":"2026-04-02","kind":"exercise","planned":true,"acquired":true,"shares":31848,"price":1.05,"value":33440.4,"ownership":{"direct":true},"balance_after":79324,"source":{"system":"sec-edgar","filing":"0001994071-26-000002","document":"form4-04032026_110446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000199407126000002/form4-04032026_110446.xml","form_type":"4"}},{"id":822787,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:39:15.000Z","date":"2026-03-30","kind":"gift","planned":false,"acquired":false,"shares":6291,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31438,"source":{"system":"sec-edgar","filing":"0001993684-26-000002","document":"form4-04012026_090411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368426000002/form4-04012026_090411.xml","form_type":"4"}},{"id":824444,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-31T11:11:39.000Z","date":"2026-03-27","kind":"purchase","planned":false,"acquired":true,"shares":25450,"price":19.67,"value":500601.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $19.67, and the range of prices were between $19.63 and $19.70, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":690704,"source":{"system":"sec-edgar","filing":"0001167496-26-000003","document":"form4-03312026_110335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749626000003/form4-03312026_110335.xml","form_type":"4"}},{"id":830779,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-24T01:23:29.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":28200,"price":20.65,"value":582330.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $20.65, and the range of prices were between $20.15 and $20.84, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":341147,"source":{"system":"sec-edgar","filing":"0001405684-26-000002","document":"form4-03242026_010325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000140568426000002/form4-03242026_010325.xml","form_type":"4"}},{"id":830778,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-24T01:23:29.000Z","date":"2026-03-20","kind":"sale","planned":false,"acquired":false,"shares":36800,"price":20.47,"value":753296.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction report was $20.47, and the range of prices were between $20.07 and $20.96, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":369347,"source":{"system":"sec-edgar","filing":"0001405684-26-000002","document":"form4-03242026_010325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000140568426000002/form4-03242026_010325.xml","form_type":"4"}},{"id":845963,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T10:05:05.000Z","date":"2026-03-11","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":21.55,"value":21550.0,"ownership":{"direct":true},"balance_after":38415,"source":{"system":"sec-edgar","filing":"0001221590-26-000003","document":"form4-03122026_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000003/form4-03122026_060301.xml","form_type":"4"}},{"id":845962,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T10:05:05.000Z","date":"2026-03-10","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":22.12,"value":22120.0,"ownership":{"direct":true},"balance_after":37415,"source":{"system":"sec-edgar","filing":"0001221590-26-000003","document":"form4-03122026_060301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000122159026000003/form4-03122026_060301.xml","form_type":"4"}},{"id":957403,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-30T23:47:24.000Z","date":"2025-12-30","kind":"purchase","planned":false,"acquired":true,"shares":4729,"price":21.15,"value":100018.35,"ownership":{"direct":true},"balance_after":665254,"source":{"system":"sec-edgar","filing":"0001167496-25-000010","document":"form4-12302025_111219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000010/form4-12302025_111219.xml","form_type":"4"}},{"id":959720,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:41:35.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":11251,"price":22.34,"value":251347.34,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2024."},{"field":"shares","element":"transactionShares","label":"F6","text":"The shares were sold as follows: 6,851 shares were sold by ABV II and 4,400 shares were sold by ABV II-B."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction report was $22.34, and the range of prices were between $22.31 and $22.38, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following this transaction, ABV II and ABV II-B own 1,238,282 shares of Issuer common stock and 792,899 shares of Issuer common stock, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Barchas is a co-founder and holder of a power of attorney with the ability to exercise voting and investment power over the shares held by ABV II and ABV II-B. Mr. Barchas disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Mr. Barchas is the beneficial owner of such shares."}],"balance_after":2031181,"source":{"system":"sec-edgar","filing":"0001808343-25-000004","document":"form4-12232025_091227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834325000004/form4-12232025_091227.xml","form_type":"4"}},{"id":959719,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-23T21:41:35.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":371949,"price":21.72,"value":8078732.28,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale of these shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold as follows: 226,480 shares were sold by Arsenal Bridge Venture II, LLC (\"ABV II\") and 145,469 shares were sold by Arsenal Bridge Venture II-B, LLC (\"ABV II-B\" and collectively with ABV II, the \"ABV Entities\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction report was $21.72, and the range of prices were between $21.31 and $22.30, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following this transaction, ABV II and ABV II-B own 1,245,133 shares of Issuer common stock and 797,299 shares of Issuer common stock, respectively."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Mr. Barchas is a co-founder and holder of a power of attorney with the ability to exercise voting and investment power over the shares held by ABV II and ABV II-B. Mr. Barchas disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares, if any. This report shall not be deemed an admission that Mr. Barchas is the beneficial owner of such shares."}],"balance_after":2042432,"source":{"system":"sec-edgar","filing":"0001808343-25-000004","document":"form4-12232025_091227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000180834325000004/form4-12232025_091227.xml","form_type":"4"}},{"id":960881,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian for Child 3"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-up Agreement\").  The transferee has agreed to be bound by the terms of the Lock-up Agreement."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960880,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."}],"balance_after":37729,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960879,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian for Child 2"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-up Agreement\").  The transferee has agreed to be bound by the terms of the Lock-up Agreement."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960878,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."}],"balance_after":38729,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960877,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Custodian for Child 1"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-up Agreement\").  The transferee has agreed to be bound by the terms of the Lock-up Agreement."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":960876,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:43:46.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the gift of shares by the Reporting Person to a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose."}],"balance_after":39729,"source":{"system":"sec-edgar","filing":"0001993684-25-000004","document":"form4-12222025_121242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199368425000004/form4-12222025_121242.xml","form_type":"4"}},{"id":961332,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-22T12:38:54.000Z","date":"2025-12-19","kind":"gift","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person gifted the shares of the Issuer's common stock to the Clay B. Siegall 2025 Grantor Retained Annuity Trust, of which the Reporting Person's brother is the trustee and the Reporting Person's children are the beneficiaries. The Reporting Person does not have or share investment control over these shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares are subject to a lockup agreement entered into by the Reporting Person on December 15, 2025 (the \"Lock-Up Agreement\"). The transferee has agreed to be bound by the terms of the Lock-Up Agreement."}],"balance_after":660525,"source":{"system":"sec-edgar","filing":"0001167496-25-000008","document":"form4-12222025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000008/form4-12222025_121251.xml","form_type":"4"}},{"id":961331,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-22T12:38:54.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":7278,"price":20.48,"value":149053.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction report was $20.48, and the range of prices were between $20.36 and $20.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":860525,"source":{"system":"sec-edgar","filing":"0001167496-25-000008","document":"form4-12222025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000008/form4-12222025_121251.xml","form_type":"4"}},{"id":961236,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28591,"kind":"person","name":"Tsai Philip","position":1,"cik":"0002026600","reported_name":"Tsai Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-12-22T12:32:54.000Z","date":"2025-12-19","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":20.49,"value":204900.0,"ownership":{"direct":true},"balance_after":43300,"source":{"system":"sec-edgar","filing":"0002026600-25-000004","document":"form4-12222025_121251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026600/000202660025000004/form4-12222025_121251.xml","form_type":"4"}},{"id":963433,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-12-18T22:03:54.000Z","date":"2025-12-18","kind":"purchase","planned":false,"acquired":true,"shares":46511,"price":21.5,"value":999986.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock."}],"balance_after":853247,"source":{"system":"sec-edgar","filing":"0001167496-25-000006","document":"form4-12182025_101250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000116749625000006/form4-12182025_101250.xml","form_type":"4"}},{"id":1042755,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock option (right to buy)","published_at":"2025-09-12T01:04:17.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":151840,"derivative":{"exercise_price":1.35,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001415889-25-024319","document":"form4-09122025_010912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925024319/form4-09122025_010912.xml","form_type":"4"}},{"id":1042754,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-09-12T01:04:17.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":22000,"price":1.35,"value":29700.0,"ownership":{"direct":true},"balance_after":40729,"source":{"system":"sec-edgar","filing":"0001415889-25-024319","document":"form4-09122025_010912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925024319/form4-09122025_010912.xml","form_type":"4"}},{"id":1078504,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28591,"kind":"person","name":"Tsai Philip","position":1,"cik":"0002026600","reported_name":"Tsai Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T23:00:44.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":190000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001415889-25-020788","document":"form4-07312025_110740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2026600/000141588925020788/form4-07312025_110740.xml","form_type":"4"}},{"id":1078491,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28573,"kind":"person","name":"Rosett Max","position":1,"cik":"0001994071","reported_name":"Rosett Max","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:59:16.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":207000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":207000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":207000},"source":{"system":"sec-edgar","filing":"0001415889-25-020787","document":"form4-07312025_100711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1994071/000141588925020787/form4-07312025_100711.xml","form_type":"4"}},{"id":1078354,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:57:22.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":242000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":242000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":242000},"source":{"system":"sec-edgar","filing":"0001415889-25-020786","document":"form4-07312025_100718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925020786/form4-07312025_100718.xml","form_type":"4"}},{"id":1078353,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":25835,"kind":"person","name":"Horn Kinney","position":1,"cik":"0001831215","reported_name":"Horn Kinney","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:55:38.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":161000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":161000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":161000},"source":{"system":"sec-edgar","filing":"0001415889-25-020785","document":"form4-07312025_100734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925020785/form4-07312025_100734.xml","form_type":"4"}},{"id":1078352,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28533,"kind":"person","name":"Higgins Jack","position":1,"cik":"0001993684","reported_name":"Higgins Jack","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:52:43.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":196000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":196000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":196000},"source":{"system":"sec-edgar","filing":"0001415889-25-020784","document":"form4-07312025_100740.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925020784/form4-07312025_100740.xml","form_type":"4"}},{"id":1078523,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28602,"kind":"person","name":"SIEGALL CLAY B","position":1,"cik":"0001167496","reported_name":"SIEGALL CLAY B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:51:09.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":800000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001415889-25-020782","document":"form4-07312025_100706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1167496/000141588925020782/form4-07312025_100706.xml","form_type":"4"}},{"id":1078351,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28534,"kind":"person","name":"Stoneman Sandra G.","position":1,"cik":"0001831144","reported_name":"Stoneman Sandra G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER & GC"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:48:48.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":190000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001415889-25-020779","document":"form4-07312025_100744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925020779/form4-07312025_100744.xml","form_type":"4"}},{"id":1113266,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":37074,"kind":"person","name":"Boylan James P","position":1,"cik":"0001953094","reported_name":"Boylan James P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T21:00:00.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Boylan has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Company's board of directors. As such, Mr. Boylan disclaims beneficial ownership of, and all right, title and interest in, the reported securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to Mr. Boylan's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016991","document":"form4-06122025_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925016991/form4-06122025_080657.xml","form_type":"4"}},{"id":1113265,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":38709,"kind":"person","name":"SCHAFER CAROL","position":1,"cik":"0001272181","reported_name":"SCHAFER CAROL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T20:58:34.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016990","document":"form4-06122025_080630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925016990/form4-06122025_080630.xml","form_type":"4"}},{"id":1113264,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":22845,"kind":"person","name":"WAGENHEIM PHILIP","position":1,"cik":"0001405684","reported_name":"WAGENHEIM PHILIP","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T20:55:55.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016987","document":"form4-06122025_080651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925016987/form4-06122025_080651.xml","form_type":"4"}},{"id":1113589,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":24152,"kind":"person","name":"Barchas Isaac","position":1,"cik":"0001808343","reported_name":"Barchas Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T20:54:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016982","document":"form4-06122025_080607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808343/000141588925016982/form4-06122025_080607.xml","form_type":"4"}},{"id":1113263,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":21586,"kind":"person","name":"BIENAIME JEAN JACQUES","position":1,"cik":"0001221590","reported_name":"BIENAIME JEAN JACQUES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-12T20:52:28.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date."}],"balance_after":18864,"derivative":{"exercise_price":9.57,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":18864},"source":{"system":"sec-edgar","filing":"0001415889-25-016980","document":"form4-06122025_080623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925016980/form4-06122025_080623.xml","form_type":"4"}}],"next_cursor":"2025-06-12T20:52:28.000000Z,1113263"}